Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Production of Biopesticides01:18

Production of Biopesticides

Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...
What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview
Synthetic Biology02:55

Synthetic Biology

Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-talk between cancer and Pseudomonas aeruginosa mediates tumor suppression.

Communications biology·2023
Same author

Bacterial azurin in potential cancer therapy.

Cell cycle (Georgetown, Tex.)·2016
Same author

Structural studies on Laz, a promiscuous anticancer Neisserial protein.

Bioengineered·2015
Same author

Bacterial proteins and peptides in cancer therapy: today and tomorrow.

Bioengineered·2014
Same author

Microbial pathogenicity: a new approach to drug development.

Advances in experimental medicine and biology·2014
Same author

Genome Sequence of the 2,4,5-Trichlorophenoxyacetate-Degrading Bacterium Burkholderia phenoliruptrix Strain AC1100.

Genome announcements·2013

Related Experiment Video

Updated: Jun 4, 2026

Small-Cage Laboratory Trials of Genetically-Engineered Anopheline Mosquitoes
07:45

Small-Cage Laboratory Trials of Genetically-Engineered Anopheline Mosquitoes

Published on: May 1, 2021

Bioengineered bugs, drugs and contentious issues in patenting.

Ananda M Chakrabarty1

  • 1Department of Microbiology & Immunology, University of Illinois College of Medicine, Chicago, IL USA. pseudomo@uic.edu

Bioengineered Bugs
|February 18, 2011
PubMed
Summary

Intellectual property rights protect bioengineered innovations. This article details obtaining a patent for a genetically modified bacterium and discusses future drug development, emphasizing broad patent protection for marketability.

Keywords:
HIV/AIDSPseudomonas aeruginosaanticancer drugsbusiness methodsdrug promiscuitylife formmalariapatenting

More Related Videos

Microinjection of Western Corn Rootworm, Diabrotica virgifera virgifera, Embryos for Germline Transformation, or CRISPR/Cas9 Genome Editing
07:42

Microinjection of Western Corn Rootworm, Diabrotica virgifera virgifera, Embryos for Germline Transformation, or CRISPR/Cas9 Genome Editing

Published on: April 27, 2018

Delivery of Nucleic Acids through Embryo Microinjection in the Worldwide Agricultural Pest Insect, Ceratitis capitata
09:45

Delivery of Nucleic Acids through Embryo Microinjection in the Worldwide Agricultural Pest Insect, Ceratitis capitata

Published on: October 1, 2016

Related Experiment Videos

Last Updated: Jun 4, 2026

Small-Cage Laboratory Trials of Genetically-Engineered Anopheline Mosquitoes
07:45

Small-Cage Laboratory Trials of Genetically-Engineered Anopheline Mosquitoes

Published on: May 1, 2021

Microinjection of Western Corn Rootworm, Diabrotica virgifera virgifera, Embryos for Germline Transformation, or CRISPR/Cas9 Genome Editing
07:42

Microinjection of Western Corn Rootworm, Diabrotica virgifera virgifera, Embryos for Germline Transformation, or CRISPR/Cas9 Genome Editing

Published on: April 27, 2018

Delivery of Nucleic Acids through Embryo Microinjection in the Worldwide Agricultural Pest Insect, Ceratitis capitata
09:45

Delivery of Nucleic Acids through Embryo Microinjection in the Worldwide Agricultural Pest Insect, Ceratitis capitata

Published on: October 1, 2016

Area of Science:

  • Biotechnology and Intellectual Property Law
  • Microbial Engineering
  • Pharmaceutical Development

Background:

  • Bioengineered microorganisms offer significant commercial potential.
  • Protecting these innovations through intellectual property rights is crucial for marketability.
  • Public disclosure can impact patent eligibility, with a limited grace period in the US.

Purpose of the Study:

  • To share personal experiences in patenting a bioengineered bacterium for oil spill cleanup.
  • To highlight potential future legal challenges in bioengineered product protection.
  • To introduce novel multi-disease-targeting drug candidates derived from microbial sources.

Main Methods:

  • Case study of a 1980 patent application for a genetically modified bacterium.
  • Discussion of legal proceedings, including a Supreme Court case.
  • Description of current efforts in developing a patent portfolio for new drug candidates.

Main Results:

  • Successful patenting of a bioengineered bacterium after extensive legal battles.
  • Identification of potential challenges and future legal issues in bioengineering patents.
  • Development of a strategy for broad and enforceable patent protection for novel therapeutics.

Conclusions:

  • Securing intellectual property rights is essential for commercializing bioengineered products.
  • Navigating the legal landscape of patents is critical for innovators in biotechnology.
  • Developing robust patent portfolios is key to protecting groundbreaking pharmaceutical discoveries.